Global Blue Biotechnology

Blue Biotechnology Comprehensive Study by Type (Pharmaceutical, Bio-Fuels, Food, Enzymes, Bio-Polymers, Others), Application (Vaccine development, Drug finding, Genomics, Others), End Users (Hospitals, Research Laboratories, Pharmaceuticals Companies, Food & Beverage Companies, Biotechnology Companies) Players and Region - Global Market Outlook to 2032

Blue Biotechnology Market by XX Submarkets | Forecast Years 2025-2032  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Blue Biotechnology Market Scope
Blue biotechnology also known as blue biotech, includes biological materials that originate from the aquatic environment, freshwater, and marine. The term ‘Blue Biotechnology’ can be classified into two sub- terms; Blue comes from the color of the water from oceans and Biotechnology is the study of biological processes, organisms, and systems to make products that increase the quality of human life. Blue Biotechnology is the function of Biotechnology to marine resources at a molecular level to extract active new ingredients or research & develop new drugs and similar other products. The rising need for Blue Biotechnological products in the pharmaceutical sector for manufacturing drugs and medicines for the different type of diseases in human beings is busting the growth of this market. Drug discovery is one of the most promising outcomes of marine biotechnology research due to the use of bio chemicals produced by marine organisms such as algae, bacteria and other invertebrates, for manufacturing new classes of medicines. Increasing demand of marine biotechnology products, increasing application of marine biotechnology in healthcare and extensive research and development activities drives the growth of this market globally. 

AttributesDetails
Study Period2020-2032
Base Year2024
UnitValue (USD Million)
Key Companies ProfiledSea Run Holdings, Inc.(United States), PICES (Canada), Donald Danforth Plant Science Center (United States), Shell Marine Products (United States), Aker BioMarine (Norway), Marinova (Australia), New England Biolabs (United States), PML Applications Ltd. (United Kingdom), GeoMarine Biotechnologies (India) and GlycoMar (Scotland)
CAGR%


Global blue biotechnology market consists of few established players accounting for the major market shares. To date, however, only one percent of biotech companies are engaged in blue biotechnology. The entry of private-labels in the market is expected to increase the competition levels in forecast years. Research Analyst at AMA estimates that Global Players will contribute to the maximum growth of Global Blue Biotechnology market throughout the predicted period.

Sea Run Holdings, Inc.(United States), PICES (Canada), Donald Danforth Plant Science Center (United States), Shell Marine Products (United States), Aker BioMarine (Norway), Marinova (Australia), New England Biolabs (United States), PML Applications Ltd. (United Kingdom), GeoMarine Biotechnologies (India) and GlycoMar (Scotland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Aker BioMarins (Norway), Samudra Biopharma Pvt. Ltd (India), Sanosil Biotech (India), Cellgen Biologicals Pvt Ltd. (India) and Nurture Aqua Technology Pvt. Ltd. (India).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Blue Biotechnology market by Type , by Application (Vaccine development, Drug finding, Genomics and Others) and Region with country level break-up.

On the basis of geography, the market of Blue Biotechnology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2024.

Market Leaders and their expansionary development strategies
In June 2023, Blue Water Biotech collaborated with IQVIA to build a medical sales representative team to market a commercial product portfolio. The medication, which is used to treat benign prostatic hyperplasia and prevent thrombotic cardiovascular events in people with peripheral artery disease or a history of myocardial infarction, respectively, stands out in this portfolio.
In March 2024, Aker BioMarine, a Norwegian company, introduced FloraMarine, a plant-based, algae-derived DHA omega-3 component. This high-strength DHA offers a clean, sustainable source, providing brands with a competitive advantage in meeting the growing customer demand for plant-based alternatives.


Influencing Trend:
Microalgae Incorporation Into Innovative Food Products

Market Growth Drivers:
Growing Issues Of Food Security And Water Availability and Ageing Population In Developed Economies

Challenges:
Stringent Regulations For Marine And Aquatic Ecosystem

Restraints:
Lack Of Awareness About The Usage Of Marine Microorganism

Opportunities:
Growing Demand Of Aquatic Biotechnology In Cosmetics Industry and Ongoing Research & Development In Blue Biotechnology

Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Blue Biotechnology Providers, Venture Capitalists and Private Equity Firms, Government Regulatory, Research Organizations and End Use Industry

Report Objectives / Segmentation Covered

By Type
  • Pharmaceutical
  • Bio-Fuels
  • Food
  • Enzymes
  • Bio-Polymers
  • Others
By Application
  • Vaccine development
  • Drug finding
  • Genomics
  • Others
By End Users
  • Hospitals
  • Research Laboratories
  • Pharmaceuticals Companies
  • Food & Beverage Companies
  • Biotechnology Companies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Issues Of Food Security And Water Availability
      • 3.2.2. Ageing Population In Developed Economies
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulations For Marine And Aquatic Ecosystem
    • 3.4. Market Trends
      • 3.4.1. Microalgae Incorporation Into Innovative Food Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blue Biotechnology, by Type, Application, End Users and Region (value and price ) (2019-2024)
    • 5.1. Introduction
    • 5.2. Global Blue Biotechnology (Value)
      • 5.2.1. Global Blue Biotechnology by: Type (Value)
        • 5.2.1.1. Pharmaceutical
        • 5.2.1.2. Bio-Fuels
        • 5.2.1.3. Food
        • 5.2.1.4. Enzymes
        • 5.2.1.5. Bio-Polymers
        • 5.2.1.6. Others
      • 5.2.2. Global Blue Biotechnology by: Application (Value)
        • 5.2.2.1. Vaccine development
        • 5.2.2.2. Drug finding
        • 5.2.2.3. Genomics
        • 5.2.2.4. Others
      • 5.2.3. Global Blue Biotechnology by: End Users (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Research Laboratories
        • 5.2.3.3. Pharmaceuticals Companies
        • 5.2.3.4. Food & Beverage Companies
        • 5.2.3.5. Biotechnology Companies
      • 5.2.4. Global Blue Biotechnology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Blue Biotechnology (Price)
      • 5.3.1. Global Blue Biotechnology by: Type (Price)
  • 6. Blue Biotechnology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2024)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sea Run Holdings, Inc.(United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. PICES (Canada)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Donald Danforth Plant Science Center (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Shell Marine Products (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Aker BioMarine (Norway)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Marinova (Australia)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. New England Biolabs (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. PML Applications Ltd. (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. GeoMarine Biotechnologies (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. GlycoMar (Scotland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Blue Biotechnology Sale, by Type, Application, End Users and Region (value and price ) (2027-2032)
    • 7.1. Introduction
    • 7.2. Global Blue Biotechnology (Value)
      • 7.2.1. Global Blue Biotechnology by: Type (Value)
        • 7.2.1.1. Pharmaceutical
        • 7.2.1.2. Bio-Fuels
        • 7.2.1.3. Food
        • 7.2.1.4. Enzymes
        • 7.2.1.5. Bio-Polymers
        • 7.2.1.6. Others
      • 7.2.2. Global Blue Biotechnology by: Application (Value)
        • 7.2.2.1. Vaccine development
        • 7.2.2.2. Drug finding
        • 7.2.2.3. Genomics
        • 7.2.2.4. Others
      • 7.2.3. Global Blue Biotechnology by: End Users (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Research Laboratories
        • 7.2.3.3. Pharmaceuticals Companies
        • 7.2.3.4. Food & Beverage Companies
        • 7.2.3.5. Biotechnology Companies
      • 7.2.4. Global Blue Biotechnology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Blue Biotechnology (Price)
      • 7.3.1. Global Blue Biotechnology by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blue Biotechnology: by Type(USD Million)
  • Table 2. Blue Biotechnology Pharmaceutical , by Region USD Million (2019-2024)
  • Table 3. Blue Biotechnology Bio-Fuels , by Region USD Million (2019-2024)
  • Table 4. Blue Biotechnology Food , by Region USD Million (2019-2024)
  • Table 5. Blue Biotechnology Enzymes , by Region USD Million (2019-2024)
  • Table 6. Blue Biotechnology Bio-Polymers , by Region USD Million (2019-2024)
  • Table 7. Blue Biotechnology Others , by Region USD Million (2019-2024)
  • Table 8. Blue Biotechnology: by Application(USD Million)
  • Table 9. Blue Biotechnology Vaccine development , by Region USD Million (2019-2024)
  • Table 10. Blue Biotechnology Drug finding , by Region USD Million (2019-2024)
  • Table 11. Blue Biotechnology Genomics , by Region USD Million (2019-2024)
  • Table 12. Blue Biotechnology Others , by Region USD Million (2019-2024)
  • Table 13. Blue Biotechnology: by End Users(USD Million)
  • Table 14. Blue Biotechnology Hospitals , by Region USD Million (2019-2024)
  • Table 15. Blue Biotechnology Research Laboratories , by Region USD Million (2019-2024)
  • Table 16. Blue Biotechnology Pharmaceuticals Companies , by Region USD Million (2019-2024)
  • Table 17. Blue Biotechnology Food & Beverage Companies , by Region USD Million (2019-2024)
  • Table 18. Blue Biotechnology Biotechnology Companies , by Region USD Million (2019-2024)
  • Table 19. South America Blue Biotechnology, by Country USD Million (2019-2024)
  • Table 20. South America Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 21. South America Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 22. South America Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 23. Brazil Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 24. Brazil Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 25. Brazil Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 26. Argentina Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 27. Argentina Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 28. Argentina Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 29. Rest of South America Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 30. Rest of South America Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 31. Rest of South America Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 32. Asia Pacific Blue Biotechnology, by Country USD Million (2019-2024)
  • Table 33. Asia Pacific Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 34. Asia Pacific Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 35. Asia Pacific Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 36. China Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 37. China Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 38. China Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 39. Japan Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 40. Japan Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 41. Japan Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 42. India Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 43. India Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 44. India Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 45. South Korea Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 46. South Korea Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 47. South Korea Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 48. Taiwan Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 49. Taiwan Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 50. Taiwan Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 51. Australia Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 52. Australia Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 53. Australia Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 54. Rest of Asia-Pacific Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 55. Rest of Asia-Pacific Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 56. Rest of Asia-Pacific Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 57. Europe Blue Biotechnology, by Country USD Million (2019-2024)
  • Table 58. Europe Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 59. Europe Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 60. Europe Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 61. Germany Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 62. Germany Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 63. Germany Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 64. France Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 65. France Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 66. France Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 67. Italy Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 68. Italy Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 69. Italy Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 70. United Kingdom Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 71. United Kingdom Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 72. United Kingdom Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 73. Netherlands Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 74. Netherlands Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 75. Netherlands Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 76. Rest of Europe Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 77. Rest of Europe Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 78. Rest of Europe Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 79. MEA Blue Biotechnology, by Country USD Million (2019-2024)
  • Table 80. MEA Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 81. MEA Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 82. MEA Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 83. Middle East Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 84. Middle East Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 85. Middle East Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 86. Africa Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 87. Africa Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 88. Africa Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 89. North America Blue Biotechnology, by Country USD Million (2019-2024)
  • Table 90. North America Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 91. North America Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 92. North America Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 93. United States Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 94. United States Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 95. United States Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 96. Canada Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 97. Canada Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 98. Canada Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 99. Mexico Blue Biotechnology, by Type USD Million (2019-2024)
  • Table 100. Mexico Blue Biotechnology, by Application USD Million (2019-2024)
  • Table 101. Mexico Blue Biotechnology, by End Users USD Million (2019-2024)
  • Table 102. Blue Biotechnology: by Type(USD/Units)
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Blue Biotechnology: by Type(USD Million)
  • Table 114. Blue Biotechnology Pharmaceutical , by Region USD Million (2027-2032)
  • Table 115. Blue Biotechnology Bio-Fuels , by Region USD Million (2027-2032)
  • Table 116. Blue Biotechnology Food , by Region USD Million (2027-2032)
  • Table 117. Blue Biotechnology Enzymes , by Region USD Million (2027-2032)
  • Table 118. Blue Biotechnology Bio-Polymers , by Region USD Million (2027-2032)
  • Table 119. Blue Biotechnology Others , by Region USD Million (2027-2032)
  • Table 120. Blue Biotechnology: by Application(USD Million)
  • Table 121. Blue Biotechnology Vaccine development , by Region USD Million (2027-2032)
  • Table 122. Blue Biotechnology Drug finding , by Region USD Million (2027-2032)
  • Table 123. Blue Biotechnology Genomics , by Region USD Million (2027-2032)
  • Table 124. Blue Biotechnology Others , by Region USD Million (2027-2032)
  • Table 125. Blue Biotechnology: by End Users(USD Million)
  • Table 126. Blue Biotechnology Hospitals , by Region USD Million (2027-2032)
  • Table 127. Blue Biotechnology Research Laboratories , by Region USD Million (2027-2032)
  • Table 128. Blue Biotechnology Pharmaceuticals Companies , by Region USD Million (2027-2032)
  • Table 129. Blue Biotechnology Food & Beverage Companies , by Region USD Million (2027-2032)
  • Table 130. Blue Biotechnology Biotechnology Companies , by Region USD Million (2027-2032)
  • Table 131. South America Blue Biotechnology, by Country USD Million (2027-2032)
  • Table 132. South America Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 133. South America Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 134. South America Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 135. Brazil Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 136. Brazil Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 137. Brazil Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 138. Argentina Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 139. Argentina Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 140. Argentina Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 141. Rest of South America Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 142. Rest of South America Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 143. Rest of South America Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 144. Asia Pacific Blue Biotechnology, by Country USD Million (2027-2032)
  • Table 145. Asia Pacific Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 146. Asia Pacific Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 147. Asia Pacific Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 148. China Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 149. China Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 150. China Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 151. Japan Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 152. Japan Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 153. Japan Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 154. India Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 155. India Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 156. India Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 157. South Korea Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 158. South Korea Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 159. South Korea Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 160. Taiwan Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 161. Taiwan Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 162. Taiwan Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 163. Australia Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 164. Australia Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 165. Australia Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 166. Rest of Asia-Pacific Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 167. Rest of Asia-Pacific Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 168. Rest of Asia-Pacific Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 169. Europe Blue Biotechnology, by Country USD Million (2027-2032)
  • Table 170. Europe Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 171. Europe Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 172. Europe Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 173. Germany Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 174. Germany Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 175. Germany Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 176. France Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 177. France Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 178. France Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 179. Italy Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 180. Italy Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 181. Italy Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 182. United Kingdom Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 183. United Kingdom Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 184. United Kingdom Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 185. Netherlands Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 186. Netherlands Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 187. Netherlands Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 188. Rest of Europe Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 189. Rest of Europe Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 190. Rest of Europe Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 191. MEA Blue Biotechnology, by Country USD Million (2027-2032)
  • Table 192. MEA Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 193. MEA Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 194. MEA Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 195. Middle East Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 196. Middle East Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 197. Middle East Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 198. Africa Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 199. Africa Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 200. Africa Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 201. North America Blue Biotechnology, by Country USD Million (2027-2032)
  • Table 202. North America Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 203. North America Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 204. North America Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 205. United States Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 206. United States Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 207. United States Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 208. Canada Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 209. Canada Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 210. Canada Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 211. Mexico Blue Biotechnology, by Type USD Million (2027-2032)
  • Table 212. Mexico Blue Biotechnology, by Application USD Million (2027-2032)
  • Table 213. Mexico Blue Biotechnology, by End Users USD Million (2027-2032)
  • Table 214. Blue Biotechnology: by Type(USD/Units)
  • Table 215. Research Programs/Design for This Report
  • Table 216. Key Data Information from Secondary Sources
  • Table 217. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blue Biotechnology: by Type USD Million (2019-2024)
  • Figure 5. Global Blue Biotechnology: by Application USD Million (2019-2024)
  • Figure 6. Global Blue Biotechnology: by End Users USD Million (2019-2024)
  • Figure 7. South America Blue Biotechnology Share (%), by Country
  • Figure 8. Asia Pacific Blue Biotechnology Share (%), by Country
  • Figure 9. Europe Blue Biotechnology Share (%), by Country
  • Figure 10. MEA Blue Biotechnology Share (%), by Country
  • Figure 11. North America Blue Biotechnology Share (%), by Country
  • Figure 12. Global Blue Biotechnology: by Type USD/Units (2019-2024)
  • Figure 13. Global Blue Biotechnology share by Players 2024 (%)
  • Figure 14. Global Blue Biotechnology share by Players (Top 3) 2024(%)
  • Figure 15. Global Blue Biotechnology share by Players (Top 5) 2024(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Sea Run Holdings, Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 18. Sea Run Holdings, Inc.(United States) Revenue: by Geography 2024
  • Figure 19. PICES (Canada) Revenue, Net Income and Gross profit
  • Figure 20. PICES (Canada) Revenue: by Geography 2024
  • Figure 21. Donald Danforth Plant Science Center (United States) Revenue, Net Income and Gross profit
  • Figure 22. Donald Danforth Plant Science Center (United States) Revenue: by Geography 2024
  • Figure 23. Shell Marine Products (United States) Revenue, Net Income and Gross profit
  • Figure 24. Shell Marine Products (United States) Revenue: by Geography 2024
  • Figure 25. Aker BioMarine (Norway) Revenue, Net Income and Gross profit
  • Figure 26. Aker BioMarine (Norway) Revenue: by Geography 2024
  • Figure 27. Marinova (Australia) Revenue, Net Income and Gross profit
  • Figure 28. Marinova (Australia) Revenue: by Geography 2024
  • Figure 29. New England Biolabs (United States) Revenue, Net Income and Gross profit
  • Figure 30. New England Biolabs (United States) Revenue: by Geography 2024
  • Figure 31. PML Applications Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. PML Applications Ltd. (United Kingdom) Revenue: by Geography 2024
  • Figure 33. GeoMarine Biotechnologies (India) Revenue, Net Income and Gross profit
  • Figure 34. GeoMarine Biotechnologies (India) Revenue: by Geography 2024
  • Figure 35. GlycoMar (Scotland) Revenue, Net Income and Gross profit
  • Figure 36. GlycoMar (Scotland) Revenue: by Geography 2024
  • Figure 37. Global Blue Biotechnology: by Type USD Million (2027-2032)
  • Figure 38. Global Blue Biotechnology: by Application USD Million (2027-2032)
  • Figure 39. Global Blue Biotechnology: by End Users USD Million (2027-2032)
  • Figure 40. South America Blue Biotechnology Share (%), by Country
  • Figure 41. Asia Pacific Blue Biotechnology Share (%), by Country
  • Figure 42. Europe Blue Biotechnology Share (%), by Country
  • Figure 43. MEA Blue Biotechnology Share (%), by Country
  • Figure 44. North America Blue Biotechnology Share (%), by Country
  • Figure 45. Global Blue Biotechnology: by Type USD/Units (2027-2032)
List of companies from research coverage that are profiled in the study
  • Sea Run Holdings, Inc.(United States)
  • PICES (Canada)
  • Donald Danforth Plant Science Center (United States)
  • Shell Marine Products (United States)
  • Aker BioMarine (Norway)
  • Marinova (Australia)
  • New England Biolabs (United States)
  • PML Applications Ltd. (United Kingdom)
  • GeoMarine Biotechnologies (India)
  • GlycoMar (Scotland)
Additional players considered in the study are as follows:
Aker BioMarins (Norway) , Samudra Biopharma Pvt. Ltd (India) , Sanosil Biotech (India) , Cellgen Biologicals Pvt Ltd. (India) , Nurture Aqua Technology Pvt. Ltd. (India)
Select User Access Type

Key Highlights of Report


Feb 2025 189 Pages 64 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Blue Biotechnology Quantitative research analysis
Global Blue Biotechnology Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Blue Biotechnology Market are by type [Pharmaceutical, Bio-Fuels, Food, Enzymes, Bio-Polymers and Others], by end use application [Vaccine development, Drug finding, Genomics and Others].
The Blue Biotechnology Market is gaining popularity and expected to see strong valuation by 2032.
  • Growing Issues Of Food Security And Water Availability
  • Ageing Population In Developed Economies

Know More About Global Blue Biotechnology Report?

Have a Query? Click Here

Other Related Reports

Hybrid Operating Room Comprehensive Study by Application (Cardiovascular applications, Neurosurgical applications, Thoracic applications, Orthopedic applications, Other), Technology (Fluoroscopy & Da...
$ 3750
Cancer Diagnostics Comprehensive Study by Type (Platform-based, Instrument-based), Application (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institute, Other), Meth...
$ 3650
Respiratory Diagnostics Comprehensive Study by Type (Mechanical Tests, OSA Diagnostic Tests, Imaging Tests, Others), Application (Hospital/Clinical Laboratories, Reference Laboratories, Physician Off...
$ 3750
Vocal Biomarkers Comprehensive Study by Type (Amplitude, Error rate, Frequency, Vocal rise or fall time, Voice tremor, Pitch, Others), Indication (Psychiatric Disorders, Neurological Disorders, Respi...
$ 3750
High-Throughput Screening Comprehensive Study by Type (Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, Services), Application (Chemical Biology Programs, Cell- & Organ-Based ...
$ 3750
Hemorrhagic Shock Treatment Comprehensive Study by Causes (Severe Burns, Deep Cuts, Gunshot Wounds, Others), Diagnosis (X-rays, Blood tests, Ultrasound, CT scan, MRI), Symptoms (Abdominal Pain, Abdom...
$ 3500